SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Sono-Tek (SOTK) - Profitable Nanotech Co.
SOTK 4.660+3.1%9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: RikRichter8/25/2007 9:13:45 PM
   of 433
 
SOTK Form 8-K for SONO-TEK CORP
21-Aug-2007

Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Stat

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On August 16, 2007, Sono-Tek Corporation (the "Company') announced that Dr. Joseph Riemer will become President of the Company effective September 1, 2007. Dr. Riemer holds a Ph.D. in Food Science and Technology from the Massachusetts Institute of Technology (MIT). Dr. Riemer joined the Company in January 2007 as VP of Engineering, with responsibility for developing a new business segment for the Company in the food industry. Prior to joining the Company, from 2001 to 2006, Dr. Riemer was the Principal of JR Consulting, a management consulting firm, specializing in the areas of Technology Transfer, Research and Development, Engineering and serving clients in the food, biotech and pharmaceutical industries. Dr. Riemer has also held leading positions with several food, food ingredients, and personal care products companies, including 7 years with the Adams Confectionary division of Pfizer where he was Director, Global Operations Development. In addition, Dr. Riemer was appointed to the Board of Directors effective August 16, 2007.

Effective September 1, 2007, Dr. Christopher L. Coccio will relinquish his duties as President and continue in his position as Chief Executive Officer. On August 16, 2007, Dr. Coccio was named Chairman of the Board of Directors, and Samuel Schwartz was named Chairman Emeritus.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext